查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404586

脸部注射剂市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2023-2030

Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen & PMMA Microspheres, Hyaluronic Acid), By Application (Facial Line Correction, Face Lift), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 172 Pages | 商品交期: 2-10个工作天内

价格

脸部注射剂市场成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，全球脸部注射剂市场规模预计将达到249.2亿美元，2023年至2030年复合年增长率为12.0%。脸部注射剂在抗老化治疗中极为重要，特别是当用于阻止色素沉着过度和过早衰老等损伤时。

所有社会经济群体中最受欢迎的治疗方法是肉毒桿菌和填充剂，它们已经获得了极大的欢迎。

人们越来越重视外观，尤其是在新兴国家，这是预计推动市场的关键因素之一。此外，消费者对微创手术偏好的改变也预计将支持市场成长。根据美国整形外科医生协会 (ASPS) 的数据，A 型肉毒桿菌和软组织填充剂是 2020 年美国实施的前五名微创手术之一。

受疫情影响，2020年第一季、第二季度非紧急整形手术暂停。冠状病毒的爆发影响了包括化妆品行业在内的所有行业，当局实施了严格的限製作为预防措施。美容产品的供应链也受到影响。整个医疗设备产业的供需链受到疫情的严重干扰。

脸部注射剂市场报告亮点

  • 按产品类型划分，A 型肉毒桿菌素预计将在整个预测期主导市场。这是最常用的微创手术之一。
  • 从应用来看，麵线矫正领域占据市场主导地位，2022 年收益占有率最大，为 33.2%。这种增长是由于越来越多地使用脸部注射剂进行美容手术，例如脸部细纹、脸部皱纹和唇纹。
  • 根据最终用途，医疗保健细分市场占据主导地位，2022 年收益占有率最大，为 46.8%。所有非侵入性治疗均由经验丰富的专业人员在这些设施中进行，包括脸部注射、非侵入性身体轮廓、活肤和雷射治疗。
  • 由于产品容易取得且拥有大量熟练的外科医生，北美在 2022 年以 39.7% 的销售份额占据市场主导地位。
  • 预计亚太地区将成为主要的产生收入中心。该地区得到了印度等国家的支持，人们对外观的日益关注预计将为该市场创造利润丰厚的机会。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章全球脸部注射剂市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 脸部注射市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章脸部注射剂市场：产品预估及趋势分析

  • 定义和范围
  • 2022年及2030年产品市场占有率
  • 细分仪表板
  • 按产品分類的全球脸部注射剂市场展望
  • 2018年至2030年市场规模、预测与趋势分析

第五章脸部注射剂市场：使用量估算与趋势分析

  • 定义和范围
  • 2022年及2030年应用市场占有率
  • 细分仪表板
  • 全球脸部注射剂市场按应用前景展望
  • 2018年至2030年市场规模、预测与趋势分析

第六章脸部注射剂市场：最终用途估计和趋势分析

  • 定义和范围
  • 2022 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的全球注射剂市场展望
  • 2018年至2030年市场规模、预测与趋势分析

第七章脸部注射剂市场：按地区估计和趋势分析

  • 2022 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2020年区域市场占有率和主要企业
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 依因素（政治/法律、经济/技术）进行 SWOT 分析
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 2018-2030 年市场规模、预测、数量与趋势分析：
  • 北美洲
    • 2018年至2030年北美脸部注射剂市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018年至2030年欧洲脸部注射剂市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 2018-2030 年亚太地区脸部注射剂市场估计与预测
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲脸部注射剂市场估计与预测，2018-2030 年
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 2018年至2030年MEA脸部注射剂市场估计与预测
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 主要製造商的最新发展和影响分析
  • 公司简介（製造商）
    • Ispen
    • Abbvie（Allergen）
    • Merz Pharma
    • Galderma
    • Revance Therapeutics
    • Sinclair Pharma
Product Code: GVR-1-68038-849-7

Facial Injectable Market Growth & Trends:

The global facial injectable market size is expected to reach USD 24.92 billion by 2030, registering a CAGR of 12.0% from 2023 to 2030, according to a new report by Grand View Research, Inc.,The facial injectables are crucial in anti-aging treatments and are particularly used to stop damage such as hyperpigmentation and early aging. The most popular treatments across all socioeconomic groups are Botox and fillers, which have gained immense popularity.

Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. Since there were stringent restrictions imposed by the authority bodies as a precaution, the coronavirus outbreak has had an impact on every industry, including the cosmetics industry. Aesthetics-related product supply chains were also impacted. The demand-supply chain across the whole medical device sector has been severely disrupted by the pandemic.

Facial Injectable Market Report Highlights:

  • Based on product, the botulinum toxin type A segment is projected to dominate the market throughout the forecast period. It is one of the most popularly used minimally invasive procedures
  • Based on application, the facial line correction segment dominated the market and accounted for the largest revenue share of 33.2% in 2022. This growth is owing to the increasing use of facial injectables for aesthetic procedures such as facial lines, wrinkles on the face, and lip lines
  • Based on end-use, the medSpa segment dominated the market and held the largest revenue share of 46.8% in 2022. All noninvasive treatments are performed in these facilities, which include facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments by experienced professionals
  • North America dominated the market with a revenue share of 39.7% in 2022 owing to the easy availability of the products and the presence of a large number of skilled surgeons
  • The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
    • 1.3.6. Data for primary interviews in North America
    • 1.3.7. Data for primary interviews in Europe
    • 1.3.8. Data for primary interviews in Asia Pacific
    • 1.3.9. Data for primary interviews in Latin America
    • 1.3.10. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Approach 1: Commodity flow analysis
    • 1.6.2. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Global Facial Injectable Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing aging population
      • 3.2.1.2. Increasing awareness and acceptance of aesthetic treatments
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory constrains
      • 3.2.2.2. High cost of procedures
  • 3.3. Facial Injectable Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Facial Injectable Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Collagen & PMMA Microspheres
    • 4.1.2. Hyaluronic Acid (HA)
    • 4.1.3. Botulinum Toxin Type A
    • 4.1.4. Calcium Hydroxylapatite (CaHA)
    • 4.1.5. Poly-L-lactic Acid (PLLA)
    • 4.1.6. Others
  • 4.2. Product Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Facial Injectable Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Collagen & PMMA Microspheres
      • 4.5.1.1. Collagen & PMMA Microspheres market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.2. Hyaluronic Acid (HA)
      • 4.5.2.1. Hyaluronic Acid (HA) market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.3. Calcium Hydroxylapatite (CaHA)
      • 4.5.3.1. Calcium Hydroxylapatite (CaHA) market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.4. Poly-L-lactic Acid (PLLA)
      • 4.5.4.1. Poly-L-lactic Acid (PLLA) market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.5. Others
      • 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 5. Facial Injectable Market: Application Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Facial Line Correction
    • 5.1.2. Lip Augmentation
    • 5.1.3. Face Lift
    • 5.1.4. Acne Scar Treatment
    • 5.1.5. Lipoatrophy Treatment
    • 5.1.6. Others
  • 5.2. Application Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Facial Injectable Market by Application Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Facial Line Correction
      • 5.5.1.1. Facial Line Correction market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.2. Lip Augmentation
      • 5.5.2.1. Lip Augmentation market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.3. Face Lift
      • 5.5.3.1. Face Lift market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.4. Acne Scar Treatment
      • 5.5.4.1. Acne Scar Treatment market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.5. Lipoatrophy Treatment
      • 5.5.5.1. Lipoatrophy Treatment market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.6. Others
      • 5.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 6. Facial Injectable Market: End-use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Medspas
    • 6.1.2. Dermatology Clinics
    • 6.1.3. Hospitals
  • 6.2. End-use Market Share, 2022 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Injectable Market by End-use Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Medspas
      • 6.5.1.1. Medspas market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.2. Dermatology Clinics
      • 6.5.2.1. Dermatology Clinics market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.3. Hospitals
      • 6.5.3.1. Hospitals market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 7. Facial Injectable Market: Regional Estimates & Trend Analysis

  • 7.1. Regional market share analysis, 2022 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2020
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
  • 7.7. North America
    • 7.7.1. North America Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.7.2. U.S.
      • 7.7.2.1. U.S. Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.7.2.2. Key Country Dynamics
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Regulatory Framework
    • 7.7.3. Canada
      • 7.7.3.1. Canada Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.7.3.2. Key Country Dynamics
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. Regulatory Framework
  • 7.8. Europe
    • 7.8.1. Europe Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.8.2. UK
      • 7.8.2.1. UK Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.2.2. Key Country Dynamics
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Regulatory Framework
    • 7.8.3. Germany
      • 7.8.3.1. Germany Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.3.2. Key Country Dynamics
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. Regulatory Framework
    • 7.8.4. France
      • 7.8.4.1. France Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.4.2. Key Country Dynamics
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Regulatory Framework
    • 7.8.5. Italy
      • 7.8.5.1. Italy Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.5.2. Key Country Dynamics
      • 7.8.5.3. Competitive Scenario
      • 7.8.5.4. Regulatory Framework
    • 7.8.6. Spain
      • 7.8.6.1. Spain Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.6.2. Key Country Dynamics
      • 7.8.6.3. Competitive Scenario
      • 7.8.6.4. Regulatory Framework
    • 7.8.7. Sweden
      • 7.8.7.1. Sweden Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.7.2. Key Country Dynamics
      • 7.8.7.3. Competitive Scenario
      • 7.8.7.4. Regulatory Framework
    • 7.8.8. Norway
      • 7.8.8.1. Norway Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.8.2. Key Country Dynamics
      • 7.8.8.3. Competitive Scenario
      • 7.8.8.4. Regulatory Framework
    • 7.8.9. Denmark
      • 7.8.9.1. Denmark Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.8.9.2. Key Country Dynamics
      • 7.8.9.3. Competitive Scenario
      • 7.8.9.4. Regulatory Framework
  • 7.9. Asia Pacific
    • 7.9.1. Asia Pacific Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.9.2. China
      • 7.9.2.1. China Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.2.2. Key Country Dynamics
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. Regulatory Framework
    • 7.9.3. Japan
      • 7.9.3.1. Japan Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.3.2. Key Country Dynamics
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. Regulatory Framework
    • 7.9.4. India
      • 7.9.4.1. India Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.4.2. Key Country Dynamics
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. Regulatory Framework
    • 7.9.5. Australia
      • 7.9.5.1. Australia Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.5.2. Key Country Dynamics
      • 7.9.5.3. Competitive Scenario
      • 7.9.5.4. Regulatory Framework
    • 7.9.6. Thailand
      • 7.9.6.1. Thailand Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.6.2. Key Country Dynamics
      • 7.9.6.3. Competitive Scenario
      • 7.9.6.4. Regulatory Framework
    • 7.9.7. South Korea
      • 7.9.7.1. South Korea Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.9.7.2. Key Country Dynamics
      • 7.9.7.3. Competitive Scenario
      • 7.9.7.4. Regulatory Framework
  • 7.10. Latin America
    • 7.10.1. Latin America Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.10.2. Brazil
      • 7.10.2.1. Brazil Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.10.2.2. Key Country Dynamics
      • 7.10.2.3. Competitive Scenario
      • 7.10.2.4. Regulatory Framework
    • 7.10.3. Mexico
      • 7.10.3.1. Mexico Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.10.3.2. Key Country Dynamics
      • 7.10.3.3. Competitive Scenario
      • 7.10.3.4. Regulatory Framework
    • 7.10.4. Argentina
      • 7.10.4.1. Argentina Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.10.4.2. Key Country Dynamics
      • 7.10.4.3. Competitive Scenario
      • 7.10.4.4. Regulatory Framework
  • 7.11. MEA
    • 7.11.1. MEA Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 7.11.2. Saudi Arabia
      • 7.11.2.1. Saudi Arabia Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.11.2.2. Key Country Dynamics
      • 7.11.2.3. Competitive Scenario
      • 7.11.2.4. Regulatory Framework
    • 7.11.3. South Africa
      • 7.11.3.1. South Africa Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.11.3.2. Key Country Dynamics
      • 7.11.3.3. Competitive Scenario
      • 7.11.3.4. Regulatory Framework
    • 7.11.4. UAE
      • 7.11.4.1. UAE Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.11.4.2. Key Country Dynamics
      • 7.11.4.3. Competitive Scenario
      • 7.11.4.4. Regulatory Framework
    • 7.11.5. Kuwait
      • 7.11.5.1. Kuwait Facial Injectable Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
      • 7.11.5.2. Key Country Dynamics
      • 7.11.5.3. Competitive Scenario
      • 7.11.5.4. Regulatory Framework

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company Profiles (Manufacturers)
    • 8.2.1. Ispen
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Abbvie (Allergen)
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Merz Pharma
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Galderma
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Revance Therapeutics
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Sinclair Pharma
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 List of Secondary Sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Facial Injectable Market: market outlook
  • Fig. 9 Facial Injectable Market competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Global Facial Injectable Market driver impact
  • Fig. 14 Global Facial Injectable Market restraint impact
  • Fig. 15 Global Facial Injectable Market strategic initiatives analysis
  • Fig. 16 Global Facial Injectable Market: Product movement analysis
  • Fig. 17 Global Facial Injectable Market: Product outlook key takeaways
  • Fig. 18 Collagen & PMMA Microspheres market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 19 Hyaluronic Acid (HA) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Botulinum Toxin Type A market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Calcium Hydroxylapatite (CaHA) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Poly-L-lactic Acid (PLLA) market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Global Facial Injectable Market: Application movement analysis
  • Fig. 25 Global Facial Injectable Market: Application outlook and key takeaways
  • Fig. 26 Facial Line Correction market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Lip Augmentation market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Face Lift market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Acne Scar Treatment Augmentation market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Lipoatrophy Treatment market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Global Facial Injectable Market: End-use movement analysis
  • Fig. 33 Global Facial Injectable Market: End-use outlook and key takeaways
  • Fig. 34 Medspas market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Dermatology Clinics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 37 Global Facial Injectable Market: regional movement analysis
  • Fig. 38 Global Facial Injectable Market: regional outlook and key takeaways
  • Fig. 39 North America Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 U.S. Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Europe. Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 UK Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 Germany Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 France Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 46 Italy Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 47 Spain Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 Sweden Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 Norway Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 51 Asia Pacific Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 52 China Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 53 Japan Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 54 India Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 Australia Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Thailand Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 South Korea Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 58 Latin America Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 59 Brazil Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Mexico Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 Argentina Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 Middle East and Africa Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 63 Saudi Arabia Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 64 South Africa Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 65 UAE Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 66 Kuwait Facial Injectable market estimates and forecast, 2018 - 2030 (USD Billion)